Question 1

What is LOPJLB’s current signal on GYRE?

Accepted Answer

LOPJLB’s latest quantitative signal on Gyre Therapeutics, Inc. (GYRE) is BUY in a RECOVERY regime. Signals are updated daily.

Question 2

What market regime is GYRE in?

Accepted Answer

Gyre Therapeutics, Inc. (GYRE) is currently classified in the RECOVERY HMM market regime on LOPJLB.

Question 3

What does Gyre Therapeutics, Inc. (GYRE) do?

Accepted Answer

Gyre Therapeutics, Inc. is a pharmaceutical company dedicated to discovering, advancing, and bringing to market small-molecule drugs that target inflammation and fibrosis in various organs. The company's key anti-fibrotic medication, ETUARY (Pirfenidone), has received approval for treating idiopathic pulmonary fibrosis. Beyond this, ETUARY is also undergoing late-stage (Phase 3) clinical trials…

Question 4

Where is Gyre Therapeutics, Inc. based / listed?

Accepted Answer

Gyre Therapeutics, Inc. is based in US, listed on NASDAQ.

Gyre Therapeutics, Inc. (GYRE)

Key stats

Prediction markets

Company news